Tuesday, September 18, 2007
Drug and Device Law has a post on two recent New York Times articles -- one on DaVita's involvement with Epogen and possible resulting litigation, and the other on interpretation of scientific studies.
Point of law's Walter Olson has a post on a $2.4 billion lead-paint abatement plan submitted by the state after defendants' were held liable in a nuisance trial.
Products Liability Prof Blog has a post regarding a Senate Judiciay Committee hearing on " “Regulatory Preemption: Are Federal Agencies Usurping Congressional and State Authority?”
Torts Prof Blog has a post linking The Examiner's multi-part series on class action abuse.